Gröbenzell, Germany

Thomas Kapsner

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Kapsner: Innovator in Antibacterial Treatments

Introduction

Thomas Kapsner is a notable inventor based in Gröbenzell, Germany. He has made significant contributions to the field of antibacterial treatments, holding a total of 3 patents. His work focuses on the development of innovative hybrid compounds that aim to improve the treatment and prophylaxis of bacterial diseases.

Latest Patents

Kapsner's latest patents include groundbreaking inventions related to oxazolidinone-quinolone hybrid antibacterials. One of his patents details the use of these hybrids for parenteral treatment, particularly intravenous administration, to combat bacterial diseases. This invention not only highlights the potential of oxazolidinone-quinolone hybrids but also introduces improved methods for their administration, enhancing their effectiveness in clinical settings.

Career Highlights

Throughout his career, Thomas Kapsner has worked with prominent companies in the pharmaceutical sector, including Morphochem Aktiengesellschaft für Kombinatorische Chemie and Morphochem GmbH. His experience in these organizations has allowed him to refine his expertise in medicinal chemistry and antibacterial research.

Collaborations

Kapsner has collaborated with notable professionals in his field, including Axel Dalhoff and Thomas Gramatte. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Thomas Kapsner's innovative work in the field of antibacterial treatments showcases his dedication to improving healthcare solutions. His patents reflect a commitment to advancing medical science and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…